Price History
Feb 9, 2026 — Mar 28, 2026Investment Snapshot
- P/B of 1.31 — trading near book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -10.4%
- Revenue growing at 849% annually
Gevo, Inc. - Common Stock (GEVO) is a Basic Materials company operating in Industrial Organic Chemicals, listed on the NASDAQ , with a market capitalisation of $612 million . Key value metrics: P/B ratio 1.31, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Gevo, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, GEVO shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -10.4% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.35.
StockPik's composite Value Score for GEVO is 48/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
GEVO reports a thin gross margin of -171.0% (sector average: 12.8%) and a negative operating margin of -35.9%.
GEVO shows revenue growing at 849% year-over-year, with earnings growing at 57%.